# Faeth Therapeutics, Inc.: Form DEF 14A, filed Apr 11, 2025

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: DEF 14A
- Filed: 2025-04-11
- Accepted by EDGAR: Apr 11, 2025, 08:00 ET
- Period: 2025-05-21
- Accession: 0000950170-25-053033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm

Filed Apr 11, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-053033. Last ingested by Listed: Nov 3, 2026, 08:41 ET. No prices; not investment advice.